Home

msgbartop

msgbarbottom

17 Apr 07 Dr.Reddy’s to participate in Pharmacopoeia’s New Pharmaceutical Ingredient Verification Programme

Dr. Reddy’s has informed both the leading Indian stock exchanges that it is the first Participant in United States Pharmacopoeia’s New Pharmaceutical Ingredient Verification Programme.

Related Posts

Sun Pharma to acquire Israel’s Taro Pharmaceutical Industries

GTL fixes buyback price

Educomp solutions wins Rs.18.3 crore order

Ranbaxy acquires Be-Tabs Pharma

Hilton Metal Forging plans to raise Rs 38.15 crore through an IPO

ABG Shipyard surges ahead of listing on the National Stock Exchange (NSE)

Aries Agro Limited IPO

Hindustan lever (HLL) Buyback

SRF Polymers Open Offer Price fixed

EID parry buy back offer approved, buyback offer price fixed

Environmental Marketing – The Way Forward?

Avon Organics Open Offer price fixed

Record date for Nandan Exim Rights Issue fixed

Garware Offshore Open Offer Price fixed

Deccan Chronicle Buy-Back offer price fixed

Filed in Company News

Leave a Comment